Emma Boldock

Emma Boldock

Auto-generated profile, based on publicly available information

Emma Boldock

The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
EBEmma Boldock
Emma Boldock
BSBas G. J. Surewaard
Bas G. J. Surewaard
DSDaria Shamarina
Daria Shamarina
MNManli Na
Manli Na
YFYing Fei
Ying Fei
SFSimon J. Foster
Simon J. Foster

1 November 2017 in Infection and Immunity
Verified
Journal Article
Open access
JCJohn Connolly
John Connolly
EBEmma Boldock
Emma Boldock
Lynne PrinceLynne Prince
Lynne Prince
SRStephen A Renshaw
Stephen A Renshaw
MWMoira K Whyte
Moira K Whyte
SFSimon J Foster
Simon J Foster
Staphylococcus aureus is a human commensal but also has devastating potential as an opportunistic pathogen. S. aureus bacteremia is often associated with an adverse outcome. To identify potential targets for novel control approaches, we have identified S. aureus components that are required for growth in human blood. An ordered transposon mutant library was screened, and 9 genes involved specifically in hemolysis or growth on human blood agar were identified by comparing the mutants to the parental strain. Three genes ( purA , purB , and pabA ) were subsequently found to be required for pathogenesis in the zebrafish embryo infection model. The pabA growth defect was specific to the red blood cell component of human blood, showing no difference from the parental strain in growth in human serum, human plasma, or sheep or horse blood. PabA is required in the tetrahydrofolate (THF) biosynthesis pathway. The pabA growth defect was found to be due to a combination of loss of THF-dependent dTMP production by the ThyA enzyme and increased demand for pyrimidines in human blood. Our work highlights pabA and the pyrimidine salvage pathway as potential targets for novel therapeutics and suggests a previously undefined role for a human blood factor in the activity of sulfonamide antibiotics.

25 April 2018 in Journal of Digestive Diseases
Verified
Journal Article
Closed access
PDF file
IDIrene D'ODorico
Irene D'ODorico
Stefano Di BellaStefano Di Bella
Stefano Di Bella
JMJacopo Monticelli
Jacopo Monticelli
Daniele Roberto GiacobbeDaniele Roberto Giacobbe
Daniele Roberto Giacobbe
EBEmma Boldock
Emma Boldock
RLROBERTO Luzzati
ROBERTO Luzzati

26 April 2019 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
SMSharla M. McTavish
Sharla M. McTavish
SSSarah J. Snow
Sarah J. Snow
ECEllie C. Cook
Ellie C. Cook
BPBruno Pichon
Bruno Pichon
SCSarah Coleman
Sarah Coleman
TSThushan I. de Silva
Thushan I. de Silva
Objective: To undertake the first detailed genomic analysis of methicillin-resistant Staphylococcus aureus (MRSA) isolated in Sri Lanka. Methods: A prospective observational study was performed on 94 MRSA isolates collected over a 4 months period from the Anuradhapura Teaching Hospital, Sri Lanka. Screening for mecA, mecC, and the Panton-Valentine leucocidin (PVL)-associated lukS-PV/lukF-PV genes and molecular characterization by spa typing was undertaken. Whole genome sequencing (WGS) and phylogenetic analysis was performed on selected multilocus sequence type (MLST) clonal complex 5 (CC5) isolates from Sri Lanka, England, Australia, and Argentina. Results: All 94 MRSA harbored the mecA gene. Nineteen spa types belonging to nine MLST clonal complexes were identified. Where origin of the sample was recorded, most isolates were from skin and soft tissue infections (70/91; 76.9%), with fewer causing bacteremia (16/91; 17.6%), empyema (3/91; 3.3%) and osteomyelitis (2/91; 2.2%). Sixty two (65.9%) isolates were PVL positive with the majority (56 isolates; 90.3%) belonging to a dominant CC5 lineage. This lineage, PVL-positive ST5-MRSA-IVc, was associated with both community and hospital-onset infections. Based on WGS, representative PVL-positive ST5-MRSA-IVc isolates from Sri Lanka, England and Australia formed a single phylogenetic clade, suggesting wide geographical circulation. Conclusions: We present the most detailed genomic analysis of MRSA isolated in Sri Lanka to date. The analysis identified a PVL-positive ST5-MRSA-IVc that is prevalent among MRSA causing clinical infections in Sri Lanka. Furthermore, this clone was also found among isolates from the United Kingdom and Australia.